HomeCompareBETS vs JNJ

BETS vs JNJ: Dividend Comparison 2026

BETS yields 71.94% · JNJ yields 2.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BETS wins by $1.12M in total portfolio value
10 years
BETS
BETS
● Live price
71.94%
Share price
$2.78
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.15M
Annual income
$308,123.11
Full BETS calculator →
JNJ
Johnson & Johnson
● Live price
2.14%
Share price
$242.49
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.5K
Annual income
$4,749.88
Full JNJ calculator →

Portfolio growth — BETS vs JNJ

📍 BETS pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBETSJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BETS + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BETS pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BETS
Annual income on $10K today (after 15% tax)
$6,115.11/yr
After 10yr DRIP, annual income (after tax)
$261,904.64/yr
JNJ
Annual income on $10K today (after 15% tax)
$182.28/yr
After 10yr DRIP, annual income (after tax)
$4,037.40/yr
At 15% tax rate, BETS beats the other by $257,867.25/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BETS + JNJ for your $10,000?

BETS: 50%JNJ: 50%
100% JNJ50/50100% BETS
Portfolio after 10yr
$590.5K
Annual income
$156,436.49/yr
Blended yield
26.49%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

BETS
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-5.7% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BETS buys
0
JNJ buys
0
No recent congressional trades found for BETS or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBETSJNJ
Forward yield71.94%2.14%
Annual dividend / share$2.00$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28%
Portfolio after 10y$1.15M$30.5K
Annual income after 10y$308,123.11$4,749.88
Total dividends collected$984.4K$15.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: BETS vs JNJ ($10,000, DRIP)

YearBETS PortfolioBETS Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$17,894$7,194.24$10,594$274.49+$7.3KBETS
2$31,178$12,031.36$11,294$360.69+$19.9KBETS
3$52,952$19,591.55$12,133$476.91+$40.8KBETS
4$87,756$31,096.97$13,156$635.42+$74.6KBETS
5$142,063$48,164.40$14,432$854.61+$127.6KBETS
6$224,877$72,869.84$16,056$1,162.76+$208.8KBETS
7$348,421$107,802.39$18,175$1,604.53+$330.2KBETS
8$528,911$156,100.17$21,009$2,252.68+$507.9KBETS
9$787,396$221,461.11$24,911$3,229.73+$762.5KBETS
10$1,150,637$308,123.11$30,458$4,749.88+$1.12MBETS

BETS vs JNJ: Complete Analysis 2026

BETSStock

Bit Brother Limited engages in the retail and distribution of specialty tea products in China. The company offers tea-based beverages, including fresh milk tea, fruit tea, milk cap tea, etc.; light meals comprising salads, sandwiches, pasta, steak, burritos, and other healthy options; and pastries, such as fresh baked bread, fresh baked cakes, frosting cakes, etc. It is also involved in the blockchain technology and digital asset mining business; and provision of business management services and license trademarks to retail store owners. The company was formerly known as Urban Tea, Inc. and changed its name to Bit Brother Limited in May 2021. Bit Brother Limited was incorporated in 2011 and is headquartered in Changsha, the People's Republic of China.

Full BETS Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this BETS vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BETS vs SCHDBETS vs JEPIBETS vs OBETS vs KOBETS vs MAINBETS vs ABBVBETS vs MRKBETS vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.